chrX-153929940-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000464845(NAA10):c.*47C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.175 in 1,100,049 control chromosomes in the GnomAD database, including 18,013 homozygotes. There are 64,991 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.15 ( 1727 hom., 5272 hem., cov: 22)
Exomes 𝑓: 0.18 ( 16286 hom. 59719 hem. )
Consequence
NAA10
ENST00000464845 3_prime_UTR
ENST00000464845 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.480
Genes affected
NAA10 (HGNC:18704): (N-alpha-acetyltransferase 10, NatA catalytic subunit) N-alpha-acetylation is among the most common post-translational protein modifications in eukaryotic cells. This process involves the transfer of an acetyl group from acetyl-coenzyme A to the alpha-amino group on a nascent polypeptide and is essential for normal cell function. This gene encodes an N-terminal acetyltransferase that functions as the catalytic subunit of the major amino-terminal acetyltransferase A complex. Mutations in this gene are the cause of Ogden syndrome. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant X-153929940-G-A is Benign according to our data. Variant chrX-153929940-G-A is described in ClinVar as [Benign]. Clinvar id is 1244939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.645 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NAA10 | NM_003491.4 | c.*47C>T | 3_prime_UTR_variant | 8/8 | ENST00000464845.6 | NP_003482.1 | ||
NAA10 | NM_001256120.2 | c.*47C>T | 3_prime_UTR_variant | 8/8 | NP_001243049.1 | |||
NAA10 | NM_001256119.2 | c.*47C>T | 3_prime_UTR_variant | 7/7 | NP_001243048.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NAA10 | ENST00000464845 | c.*47C>T | 3_prime_UTR_variant | 8/8 | 1 | NM_003491.4 | ENSP00000417763.1 |
Frequencies
GnomAD3 genomes AF: 0.155 AC: 17082AN: 110399Hom.: 1728 Cov.: 22 AF XY: 0.162 AC XY: 5271AN XY: 32629
GnomAD3 genomes
AF:
AC:
17082
AN:
110399
Hom.:
Cov.:
22
AF XY:
AC XY:
5271
AN XY:
32629
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.267 AC: 48096AN: 179935Hom.: 6639 AF XY: 0.270 AC XY: 17560AN XY: 64943
GnomAD3 exomes
AF:
AC:
48096
AN:
179935
Hom.:
AF XY:
AC XY:
17560
AN XY:
64943
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.178 AC: 175675AN: 989598Hom.: 16286 Cov.: 19 AF XY: 0.201 AC XY: 59719AN XY: 296498
GnomAD4 exome
AF:
AC:
175675
AN:
989598
Hom.:
Cov.:
19
AF XY:
AC XY:
59719
AN XY:
296498
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.155 AC: 17078AN: 110451Hom.: 1727 Cov.: 22 AF XY: 0.161 AC XY: 5272AN XY: 32691
GnomAD4 genome
AF:
AC:
17078
AN:
110451
Hom.:
Cov.:
22
AF XY:
AC XY:
5272
AN XY:
32691
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 19, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at